Ken Griffin Optimize Rx Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$7.2 - $11.23 $95,040 - $148,236	-13,200 Reduced 42.17%	18,100 $139,000
Q2 2024 Aug 14, 2024	BUY	$8.8 - $13.17 $265,760 - $397,734	30,200 Added 2745.45%	31,300 $313,000
Q1 2024 May 15, 2024	SELL	$11.47 - $16.17 $221,371 - $312,081	-19,300 Reduced 94.61%	1,100 $13,000
Q4 2023 Feb 14, 2024	BUY	$7.06 - $14.49 $12,002 - $24,633	1,700 Added 9.09%	20,400 $291,000
Q3 2023 Nov 14, 2023	BUY	$7.43 - $14.96 $29,720 - $59,840	4,000 Added 27.21%	18,700 $145,000
Q2 2023 Aug 14, 2023	SELL	$11.63 - $15.63 $103,507 - $139,107	-8,900 Reduced 37.71%	14,700 $210,000
Q1 2023 May 15, 2023	BUY	$12.54 - $19.38 $136,686 - $211,242	10,900 Added 85.83%	23,600 $345,000
Q4 2022 Feb 14, 2023	BUY	$13.77 - $22.04 $17,901 - $28,652	1,300 Added 11.4%	12,700 $213,000
Q3 2022 Nov 14, 2022	SELL	$13.74 - $30.13 $46,716 - $102,442	-3,400 Reduced 22.97%	11,400 $169,000

12.2M

800

18.1K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $96.1M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.